The California Institute for Regenerative Medicine (CIRM) is a state agency established by the people of California to accelerate stem cell, regenerative medicine, and gene therapy research. As part of its mission, CIRM advances transformative treatments for serious diseases while prioritizing equity and access for diverse communities across ...

The California Institute of Regenerative Medicine (CIRM) is the first-ever taxpayer-funded agency in the US and one of the world’s largest institutes of its kind dedicated to accelerating the development of innovative cell and gene therapies.

Explore CIRM Funding Programs Discovery Supports early-stage basic research that advances the understanding of how genetic therapies work and explores groundbreaking treatments and technologies.

By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients. Check out our portfolio of awards below.

Welcome to the frequently asked questions (FAQs) page of the California Institute for Regenerative Medicine (CIRM). Here, you’ll find answers to the most common questions you may have on CIRM. Overview

CIRM funds clinical trials across a broad range of diseases and conditions that include rare and genetic disorders, treatment-resistant and refractory diseases, and many forms of cancer. Our involvement in the clinical trial process is vital to transforming potential treatments into available therapies by accelerating pathways to commercialization.

2025年2月3日 · As outlined in Proposition 14, one of the goals of the California Institute for Regenerative Medicine (CIRM) is to help accelerate discoveries that enhance our understanding of central nervous system (CNS) disorders. As part of this goal, CIRM launched the Research using Multidisciplinary, …

2024年2月23日 · [email protected]. South San Francisco, CA, Feb. 23, 2024 – The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $56 million to fund various clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers.

6 天之前 · Members of the public are invited to attend CIRM governing board meetings and to provide comment on agenda items. On this page we list agendas for all public meetings, including meetings of the Governing Board, its subcommittees, …

In support of this mission, CIRM is pleased to introduce ReMIND (Research using Multidisciplinary, Innovative approaches in Neuro Diseases), a vital new initiative that aims to accelerate discoveries that advance our understanding of Central …